Brief: Advent International To Acquire A Significant Stake In Suven Pharmaceuticals From Jasti Family
Dec 26 (Reuters) - Suven Pharmaceuticals Ltd SUVH.NS :
* JASTI PROPERTY AND EQUITY HOLDINGS EXECUTED A SHARE
PURCHASE
AGREEMENT WITH BERHYANDA LTD
* ADVENT INTERNATIONAL TO ACQUIRE A SIGNIFICANT STAKE IN CO
FROM
JASTI FAMILY
* ADVENT INTENDS TO EXPLORE MERGER OF ITS PORTFOLIO CO,
COHANCE
LIFESCIENCES WITH SUVEN
* ADVENT TO ALSO MAKE OPEN OFFER TO ACQUIRE ADDITIONAL 26%
OF
OUTSTANDING EQUITY SHARES OF CO FROM PUBLIC SHAREHOLDERS
Source text for Eikon: ID:nNSEbVcycj
Further company coverage: SUVH.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss